American digital health company focused on weight management and behavioral health
The administration has moved to allow some popular, yet unproven, injectable peptides to be temporarily manufactured by specialty pharmacies. The plan, still subject to White House review, would use enforcement discretion to avoid immediate enforcement of current restrictions, while a formal rulemaking process could take years.